Access cutting-edge hereditary transthyretin-mediated (hattr) amyloidosis treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Iowa City location
Preparing your pre-screening questions…
Access hereditary transthyretin-mediated (hattr) amyloidosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hereditary transthyretin-mediated (hattr) amyloidosis treatment provided free
Check if you qualify for this hereditary transthyretin-mediated (hattr) amyloidosis clinical trial in Iowa City, IA
No-Cost Study Care
Local to Iowa City
Convenient for IA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to collect and evaluate pregnancy outcomes, pregnancy complications, and fetal/neonatal/infant outcomes in women exposed to patisiran-LNP.
Sponsor: Alnylam Pharmaceuticals
Yes, this clinical trial (NCT05040373) has an active research site in Iowa City, IA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hereditary transthyretin-mediated (hattr) amyloidosis treatment options in Iowa City, IA, this clinical trial (NCT05040373) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hereditary transthyretin-mediated (hattr) amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hereditary transthyretin-mediated (hattr) amyloidosis clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Iowa City — not just this study.
Browse Essential Tremor Trials in Iowa City →